Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001450324-20-000008

CEO bought 14,535 shares at $1.72 ($25,000)

From the SEC's structured data for this filing

Trades in this filing

EQUELS THOMAS K. · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-12-17 Purchase : show line 1 in the form +14,535 $1.72 $25,000 198,568 D
Open-market purchases · 14,535 sh · avg $1.72 · $25,000
Loading xslF345X03/primary_doc.xml…